FMA
SCLN

FNY Managed Accounts’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

FNY Managed Accounts’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-560
Closed -$6K – 935
2017
Q3 		$6K Buy
+560
New +$6K 0.01% 473
2015
Q3 		– Sell
-1,900
Closed -$18.7K – 540
2015
Q2 		$18.7K Buy
+1,900
New +$18.7K 0.02% 229